Alexandria Equities No. 7, LLC

CIK 1776437 · last filed 2024-06-06

Alexandria Equities No. 7, LLC is a corporate insider who has filed 3 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider sold $3.8M of APLT on Jun 6, 2024. Across all open-market trades the lifetime net is −$2.5M, making them a net seller over the disclosed history. The firm reports its address in Pasadena, CA. 10 SEC filings were submitted jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

1

Total Filings

3

Lifetime Open-Market Net

-$2.52M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address

26 NORTH EUCLID AVENUE
PASADENA, CA 91101

Phone

(626) 578-0777

State of Incorporation

Related Filers

ALEXANDRIA REAL ESTATE EQUITIES, INC. — 10 joint filings, latest 2024-06-06

Alexandria Venture Investments, LLC — 10 joint filings, latest 2024-06-06

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Applied Therapeutics, Inc. (APLT) Delisted	10%+ Owner	5,855,077	$0.10	$603.1K	-$2.52M	3	2024-06-06

Recent Filings

3 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2024-06-06	Applied Therapeutics, Inc. (APLT) Delisted	Sell (S)	−900,000	-$3.80M	EDGAR
2023-11-06	Applied Therapeutics, Inc. (APLT) Delisted	Sell (S)	−741,774	-$1.72M	EDGAR
2021-02-19	Applied Therapeutics, Inc. (APLT) Delisted	Mixed	+130,434	$3.00M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.